159 related articles for article (PubMed ID: 8819508)
1. Gallium arsenide selectively suppresses antigen processing by splenic macrophages for CD4+ T cell activation.
Lewis TA; Munson AE; McCoy KL
J Pharmacol Exp Ther; 1996 Sep; 278(3):1244-51. PubMed ID: 8819508
[TBL] [Abstract][Full Text] [Related]
2. Gallium arsenide augments antigen processing by peritoneal macrophages for CD4+ helper T cell stimulation.
Hartmann CB; McCoy KL
Toxicol Appl Pharmacol; 1996 Dec; 141(2):365-72. PubMed ID: 8975760
[TBL] [Abstract][Full Text] [Related]
3. Direct exposure to gallium arsenide upregulates costimulatory activity of murine macrophages.
Caffrey-Nolan RE; McCoy KL
Toxicol Appl Pharmacol; 1998 Aug; 151(2):330-9. PubMed ID: 9707509
[TBL] [Abstract][Full Text] [Related]
4. Suppression of splenic accessory cell function in mice exposed to gallium arsenide.
Sikorski EE; Burns LA; McCoy KL; Stern M; Munson AE
Toxicol Appl Pharmacol; 1991 Aug; 110(1):143-56. PubMed ID: 1714636
[TBL] [Abstract][Full Text] [Related]
5. Gallium arsenide exposure impairs processing of particulate antigen by macrophages: modification of the antigen reverses the functional defect.
Hartmann CB; McCoy KL
Life Sci; 2004 Jun; 75(4):485-98. PubMed ID: 15147834
[TBL] [Abstract][Full Text] [Related]
6. Gallium arsenide exposure impairs splenic B cell accessory function.
Gondre-Lewis TA; Hartmann CB; Caffrey RE; McCoy KL
Int Immunopharmacol; 2003 Mar; 3(3):403-15. PubMed ID: 12639818
[TBL] [Abstract][Full Text] [Related]
7. Gallium arsenide modulates proteolytic cathepsin activities and antigen processing by macrophages.
Lewis TA; Hartmann CB; McCoy KL
J Immunol; 1998 Sep; 161(5):2151-7. PubMed ID: 9725206
[TBL] [Abstract][Full Text] [Related]
8. Gallium arsenide differentially affects processing of phagolysosomal targeted antigen by macrophages.
Lewis TA; Hartmann CB; McCoy KL
J Leukoc Biol; 1998 Mar; 63(3):321-30. PubMed ID: 9500519
[TBL] [Abstract][Full Text] [Related]
9. Splenic cell targets in gallium arsenide-induced suppression of the primary antibody response.
Sikorski EE; Burns LA; Stern ML; Luster MI; Munson AE
Toxicol Appl Pharmacol; 1991 Aug; 110(1):129-42. PubMed ID: 1871769
[TBL] [Abstract][Full Text] [Related]
10. delta 9-Tetrahydrocannabinol modulates antigen processing by macrophages.
McCoy KL; Gainey D; Cabral GA
J Pharmacol Exp Ther; 1995 Jun; 273(3):1216-23. PubMed ID: 7791094
[TBL] [Abstract][Full Text] [Related]
11. Gallium arsenide selectively inhibits T cell proliferation and alters expression of CD25 (IL-2R/p55).
Burns LA; Munson AE
J Pharmacol Exp Ther; 1993 Apr; 265(1):178-86. PubMed ID: 8097242
[TBL] [Abstract][Full Text] [Related]
12. Reversal of gallium arsenide-induced suppression of the antibody-forming cell response by vehicle supernatants. I. Pharmacokinetics after in vitro and in vivo exposure.
Burns LA; Munson AE
J Pharmacol Exp Ther; 1993 Apr; 265(1):144-9. PubMed ID: 8386233
[TBL] [Abstract][Full Text] [Related]
13. Immunotoxicity of the semiconductor gallium arsenide in female B6C3F1 mice.
Sikorski EE; McCay JA; White KL; Bradley SG; Munson AE
Fundam Appl Toxicol; 1989 Nov; 13(4):843-58. PubMed ID: 2695379
[TBL] [Abstract][Full Text] [Related]
14. Immunotoxicity of gallium arsenide on antigen presentation: comparative study of intratracheal and intraperitoneal exposure routes.
Hartmann CB; Harrison MT; McCoy KL
J Immunotoxicol; 2005 Jan; 2(1):1-9. PubMed ID: 18958654
[TBL] [Abstract][Full Text] [Related]
15. Gallium arsenide selectively up-regulates inflammatory cytokine expression at exposure site.
Becker SM; McCoy KL
J Pharmacol Exp Ther; 2003 Dec; 307(3):1045-53. PubMed ID: 14560044
[TBL] [Abstract][Full Text] [Related]
16. Impact of in vitro gallium arsenide exposure on macrophages.
Harrison MT; Hartmann CB; McCoy KL
Toxicol Appl Pharmacol; 2003 Jan; 186(1):18-27. PubMed ID: 12583989
[TBL] [Abstract][Full Text] [Related]
17. Impact of 15-deoxyspergualin on effector cells in experimental autoimmune diseases of the nervous system in the Lewis rat.
Jung S; Toyka KV; Hartung HP
Clin Exp Immunol; 1994 Dec; 98(3):494-502. PubMed ID: 7527745
[TBL] [Abstract][Full Text] [Related]
18. Gallium arsenide-induced increase in serum corticosterone is not responsible for suppression of the IgM antibody response.
Burns LA; Spriggs TL; Fuchs BA; Munson AE
J Pharmacol Exp Ther; 1994 Feb; 268(2):740-6. PubMed ID: 7509391
[TBL] [Abstract][Full Text] [Related]
19. Evidence for arsenic as the immunosuppressive component of gallium arsenide.
Burns LA; Sikorski EE; Saady JJ; Munson AE
Toxicol Appl Pharmacol; 1991 Aug; 110(1):157-69. PubMed ID: 1651571
[TBL] [Abstract][Full Text] [Related]
20. A subset of splenic macrophages process and present native antigen to naive antigen-specific CD4+ T-cells from mice transgenic for an alpha beta T-cell receptor.
Askew D; Gatewood J; Olivas E; Havenith K; Walker WS
Cell Immunol; 1995 Nov; 166(1):62-70. PubMed ID: 7585982
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
